Mabpharm Ltd 02181.HK 价格预测与展望

主页

股票

02181.HK

预测

MABPHARM-B (02181.HK)

Mabpharm Ltd

HK$0.51

休市： Feb 16, 12:00:00 HKT

关键数据

前收盘价

$0.51

开盘价

$0.51

当日区间

$0.51 - $0.51

52周范围

$0.25 - $0.94

交易量

平均成交量

89.7K

每股收益（TTM）

-0.01

股息收益率

市值

$2.1B

什么是 MABPHARM-B？

Mabpharm Ltd. engages in the research, development, and manufacture of monoclonal antibody drugs for the treatment of cancer and autoimmune diseases. The company is headquartered in Taizhou, Jiangsu and currently employs 383 full-time employees. The company went IPO on 2019-05-31. The Company’s main products include CMAB009 Enlituo (cetuximab β injection), CMAB007 Aomaishu (Omalizumab α for Injection), CMAB008 Leiting (infliximab for injection) and other products. The Company’s products are mainly used for colorectal cancer, asthma, urticaria, rheumatoid arthritis, ulcerative colitis in adults and other diseases. The firm is also engaged in the transfer of intellectual property. The firm mainly conducts its business in the domestic market.

功能特性

资源

市场

02181.HK 股价预测摘要

02181.HK stock price ended at $0.51 on 星期四, after rising 0.00%

On the latest trading day Feb 12, 2026, the stock price of 02181.HK rose by 0.00%, climbing from $0.51 to $0.51. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.51 and a high of $0.51. Alongside this price increase, trading volume also rose by 18.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, -- shares were traded, amounting to a market value of approximately $2.1B.

02181.HK 技术面信号

技术面信号摘要

购买信号 2

中性信号 1

卖出信号 4

Strong Sell

Sell

Neutral

Buy

Strong Buy

02181.HK目前显示2个买入信号和4个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为--。总体而言，技术指标显示中期前景为Sell。

02181.HK 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 02181.HK 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

Mabpharm Ltd（02181.HK）价格

02181.HK 股价走势图